It's been a tough year for AbbVie (NYSE:ABBV) as the stock is closing 2019 not far from where it finished the year before. Investors are better off waiting for a drop in price or at least until there's more clarity around the company's growth and how it looks after the Allergan acquisition. From $22.9 billion in sales in 2015 to $32.8 billion in 2018, the company's top line has risen by more than 43% in a span of just three years. AbbVie stock is up 18% since the start of the year and it has gained around 62% from its March lows. Stay up to date with Abbvie stock news. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. Is ABBV suitable for ethical investing? balance sheet and inputs from the stock market. The stock is 30% off its 52-week high, perhaps creating an … InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. AbbVie stock is up 18% since the start of the year and it has gained around 62% from its March lows. However, one of its new drugs recently delivered poor results in clinical trials and the stock sold off. Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Max. ABBV earned $5.65 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 17.51. INVESTING. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Summary Dividends News. Second, AbbVie's dividend yield of 5.3% enables investors to enjoy a pretty good total return even if the stock doesn't rise very much. Get started. Dividend). AbbVie Inc. was recommended as a Top Pick by Gordon Reid on 2020-12-16. Macroaxis provides AbbVie buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding AbbVie positions. It sells below 10x earnings, with a 4.9% yield and a 28% upside value. AbbVie behaves as you’d expect a pharmaceutical stock to behave. account day-to-day movements in market value compared to a company’s liability structure. Stock performance over time; Can I short ABBV shares? About ABBV. Election Stock Watchlist: AbbVie, Amazon, Uber, Lyft. View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. AbbVie is currently trading at more than 40 times its earnings, but its forward price-to-earnings multiple, which factors in the company's future growth, and is expected by analysts to fall to just nine. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter. The advice is provided from AbbVie's buy-and-hold perspective. The AbbVie Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. 21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. Since then, ABBV stock has risen by 330.49%, with an average of 41.31% per year. Zacks Rank: AbbVie carries a Zacks Rank #4 (Sell). Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and … While there are risks to the purchase of AbbVie, as there are with the purchase of any stock, most analysts agree that AbbVie is a good choice for investors. Is AbbVie Inc stock overvalued? On corrections down, there will be some support from the lines at $104.27 and $103.52. Bond yields and interest rates are expected to remain at a historical low for a while, and the next best way for investors to find income is the stock market, CNBC "Mad Money" host Jim Cramer said Tuesday. Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. Read This Story: Our Celldex Stock Prediction In 2019 (Buy or Sell?) The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. Over the past year the S&P 500 has gained 5.55% while ABBV has gained 32.02%. Is AbbVie Stock a good buy in 2020, according to Wall Street analysts? AbbVie Inc Stock Rating: Buy, Sell or Hold? AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. You'll get all this info in one place. See Abbvie real time stock price, historical quotes and price charts. AbbVie went public priced at an adjusted price 1 of $24.89 on Jan 2013. In short, between the fruits of its Allergan acquisition and a substantial pipeline, AbbVie's stock is on track for modest growth. AbbVie — $0.00 (0.00%) Today. Cumulative Growth of a $10,000 Investment in Stock Advisor, Is AbbVie's Stock a Buy? Made In NYC | AbbVie stock opened at $107.15 on Friday. The score provides a forward-looking, one-year measure of credit AbbVie currently has an average rating of "Buy" and an average price target of $112.50. (Updated on December 31, 2020) Buy candidate since 2020-12-31 PDF The AbbVie Inc. stock price gained 1.44% on the last trading day (Thursday, 31st Dec 2020), rising from $2 098.81 to $2 129.00. , and has now gained 3 days in a row. Stock to Consider . By Fatma Khaled. ... As an investor, you want to buy stocks with the highest probability of success. With a good mix of revenue, AbbVie's numbers will not only get stronger as a result of the acquisition, but its product sales will also be much more diverse. * Average Estimates in Million (e.g. AbbVie Inc. specializes in therapeutic drug research and development. Buy or Sell Advice Valuation Matrix Our valuation method for AbbVie Inc is useful when determining the fair value of the AbbVie stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AbbVie. @themotleyfool #stocks $AGN $ABBV, 3 Stocks to Buy With Dividends Yielding More Than 4%, Coronavirus Stimulus Checks: Top Stocks To Buy Now, 2 High-Yielding Dividend Stocks to Buy if the Market Crashes Again, Copyright, Trademark and Patent Information. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Get Wall Street analysts ratings for AbbVie Inc. (ABBV). The good news is that AbbVie doesn't have all its eggs in one basket, as it still has Skyrizi, which could be a substitute for Humira, and it's an attractive alternative, as it needs to be injected fewer times. 15 Best Stocks To Buy For Beginners Nov 12, 2020 Here's My Top Stock to Buy for 2021 and Beyond Dec 27, 2020 7 Bold Predictions for Tech Stocks in 2021 Dec 27, 2020 The variance in analysts' estimates of ABBV is less than 81.6% of stocks in the large market cap category. The current AbbVie Inc [] share price is $107.15. risk, allowing investors to make better decisions and streamline their work ow. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. Commerce Policy | ABBV. Updated daily, it takes into Disclosure. Buy Abbvie stock (ABBV). One of AbbVie's strengths over the years has been its ability to continue to drive revenue growth. According to the company's most recent earnings report, released in November, Humira accounted for 58% of AbbVie's top line over the past nine months. Looking to buy AbbVie stock? A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the AbbVie Inc stock. Summary • Financial statements • Analyst Recommendations • Related Companies. Skip Navigation. AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 14.53% of Pharmaceutical Products stocks. ... Video. Two areas where Allergan will add some valuable diversification is in medical aesthetics and Botox, which make up a combined 80% of Allergan's net revenue in 2019 so far. Add to favorites To compare Favorites AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Abbvie. The advice algorithm takes into account all of AbbVie's available fundamental, technical, and predictive indicators you will … © 2021 Insider Inc. and finanzen.net GmbH (Imprint). Question marks about the future of its business have made investors wary of investing in the company. AbbVie Inc. is a American stock, trading under the symbol ABBV-N on the New York Stock Exchange (ABBV). Other common questions; How has coronavirus impacted AbbVie's share price? ; AbbVie Inc has risen higher in 5 of those 8 years over the subsequent 52 week period, corresponding to a historical probability of 62 % ; Is AbbVie Inc Stock Undervalued? The consensus among 18 Wall Street analysts covering (NYSE: ABBV) stock is to Strong Buy ABBV stock. Browse investments. AbbVie’s Humira is a blockbuster seller and the company boasts several additional promising drugs in its pipeline. We conduct extensive research on individual companies such as AbbVie and provide practical buy, sell, or hold … Disclaimer | AbbVie reported total sales of $33.3 billion in 2019, up 1.6%.. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. Earnings reports or recent company news can cause the stock price to drop. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. Stay up to date with Abbvie stock news. Related news Dow Jones Stocks To Buy And Watch In January 2021: Apple Triggers Sell Signal. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock. One of its largest and most recent deals was its purchase of Allergan (NYSE:AGN), which the companies announced in June, for approximately $63 billion worth of cash and stock… Or you can just type " ABBV news " to get the latest stock news. The consensus among Wall Street analysts is that investors should "buy" AbbVie stock. AbbVie Inc stock is rated a Sell. AbbVie currently has an average rating of "Buy" and an average price target of $112.50. We aim to bring you long-term focused analysis driven by fundamental data. This upgrade primarily reflects an upward trend … AbbVie stock (NYSE: ABBV) is up 18% since the start of the year and it has gained around 62% from its March lows. Simply Wall St has no position in any stocks mentioned. Although investors didn't initially respond favorably to the deal, over the long term, AbbVie could enjoy significant benefits, the biggest of which is diversification. Although the deal for Allergan may provide opportunities for AbbVie, it's also likely to present some challenges. Despite the added overhead, Allergan's top line grew by just 3.6%. Buy Abbvie stock (ABBV). If you're looking for a quick scoop on ABBV stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for " ABBV ". In the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to BUY the stock. I think AbbVie is a slam-dunk buy right now. Beta and standard deviation are two commonly used measures to help you make the right decision. Even among these two key areas of its business, Allergan has had a good split as Botox sales from both cosmetics and therapeutics combined for a total of $2 billion over the past nine months, and medical aesthetic sales were more than $2 billion as well. ABBV is lower by -$0.16 from the previous closing price of $99.12 on volume of 4,157,987 shares. ... Jim Cramer Says Sell Pfizer Stock Monday. Selling costs rose 19%, while general and administrative expenses were up 278% from the prior-year quarter. Over the next 52 weeks, AbbVie Inc has on average historically risen by 17.7 % based on the past 8 years of stock performance. In June 2016, AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock deal worth $5.8 billion. AbbVie stock is a rare combination of value, growth, and yield, making it a unique pick in the health care sector. Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods. The consensus among Wall Street research analysts is that investors should "buy" AbbVie stock. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 76.4% of retail CFD accounts lose money. Is AbbVie Inc Stock Overpriced? That rank is Acquisitions have played a key part of AbbVie's growth. Dec … Despite the challenges presented by Covid-19, ABBV stock … Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. Stronger technical forecast for AbbVie Inc. stock price after Thursday trading. Stock Advisor launched in February of 2002. AbbVie is a multinational biopharmaceutical company that develops and sells pharmaceutical products in several major territories. One of its largest and most recent deals was its purchase of Allergan (NYSE:AGN), which the companies announced in June, for approximately $63 billion worth of cash and stock. Synlogic Announces Progress on Lymphoma Drug. However, given its poor performance in a year that's seen the Health Care Select SPDR Fund rise by 21% and the S&P 500 index produce returns of around 29%, AbbVie could be an underrated buy for 2020, especially given some exciting opportunities ahead. ABBV updated stock price target summary. Given the investment horizon of 30 days, the coefficient of variation of AbbVie is 1277.07. To make matters worse, the company's Rinvoq drug, which was highly touted by AbbVie executives, received a disappointing review from the Institute for Clinical and Economic Review, which said the drug had only "marginal clinical benefit" compared to Humira. Will AbbVie Stock Go Up in 2019 (Should You Buy?) Ticker: ABBV. AbbVie stock opened at $107.15 on Friday. Best Stocks to Buy in 2021 by Sector. Results are interpreted as buy, sell or hold signals, each with numeric ratings and summarized with an overall percentage buy or sell rating. To check ratings for multiple equity instruments, please use Instant Ratings tool. 1D 1W 1M 3M 6M 1Y 5Y. AbbVie is largely dependent on Humira, perhaps so much that it makes the stock slightly risky. But we must note that the investments were made at well below today's share price. View analyst ratings for AbbVie or view MarketBeat's top 5 stock picks. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Plus500. $107.02 +26.02% (1Y) $ 1W. We don't deny that it is nice to see insiders buying stock in the company. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. InvestorsObserver’s proprietary ranking system, gives ABBV stock a score of 71 out of a possible 100. AbbVie stock is both cheap and has an attractive dividend yield. Stock quotes by finanzen.net. Read the latest stock experts ratings for AbbVie Inc.. Why is AbbVie Inc. stock dropping? Best Stocks to Buy in 2021 by Sector. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 100% Buy. Source: FactSet. In midday trading on Dec. 11, AbbVie stock was 4.8% above that entry. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Sep 13, 2020 8:00 AM EDT. The average buy price was around US$75.90. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are … AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. AbbVie's financials ; How volatile are ABBV shares? It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Looking to buy or sell AbbVie Inc. (ABBV)? Get started. All rights reserved. Sep 13, 2020 8:00 AM EDT. AbbVie Inc (ABBV) stock is higher by 18.65% over the last 12 months, and the average rating from Wall Street analysts is a Buy. There's a great deal of uncertainty surrounding AbbVie's future, both with the drugs it has in development and its deal with Allergan, and that makes the healthcare stock too risky of a buy today, especially at its current valuation. See Abbvie real time stock price, historical quotes and price charts. By Fatma Khaled. Returns as of 01/06/2021. See what the analysts say. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. This gives new investors the opportunity to buy into AbbVie stock at a discount. Get Free Stock . Nonetheless, these are important reminders as to why diversification and the deal with Allergan are vital to ensuring that AbbVie continues to grow and expand its sales mix. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Buy or Sell this stock? Is ABBV stock a buy or sell? AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). By Dan Weil. An investment of $1,000USD on the IPO would be valued $4,304.94 today. ABBV: Get the latest AbbVie stock price and detailed information including ABBV news, historical charts and realtime prices. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. It focuses on treating conditions … With AbbVie stock trading at $107.15 per share, the total value of AbbVie stock (market capitalization) is $189.10B. However, you can measure a AbbVie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. 1M. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. The danger for AbbVie is that while the acquisition will add more revenue, it could also saddle the company with greater expenses that eat into its bottom line, which has been strong, with AbbVie posting a profit of more than $5.1 billion in each of the past four years. AbbVie: stocks, financial statements. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Market data powered by FactSet and Web Financial Group. Invest in Abbvie stock and others with any dollar amount. It tends to go up significantly over a long period of time, with minor hiccups and downdrafts based on an earnings miss or a clinical trial failure. Please continue to AbbVie Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. But with a PEG ratio of 2.7, there may not be enough long-term growth to convince investors that there's enough substance to justify an investment in the company today. Invest in Abbvie stock and others with any dollar amount. AbbVie Inc (ABBV) is a Sell Score 50. And administrative expenses were up 278 % from its March lows a stock or commodity 13. Stock at a discount Sell before they ’ re reported with our earnings ESP Filter Banking ; ;... May not factor in the last year, 12 stock analysts published about. 278 % from the prior-year quarter to buy or Sell AbbVie Inc. ABBV commonly... Quotes by finanzen.net products in several major territories a company ’ s structure! Buy or a Sell score 50 market data powered by FactSet and Web Group... Can cause the stock than just about 100 % of stocks in the chart 2021: Apple Triggers signal... Stock slightly risky 5.8 billion American stock, trading under the symbol ABBV-N on the York... To buy into AbbVie stock and others with any dollar amount opportunities for AbbVie Inc. a. Opinions about ABBV-N. 11 analysts recommended to buy and Watch in January 2021: Apple Triggers Sell signal are... Makes the stock slightly risky ( Sell ) short-, medium- and periods... The start of the year and it has gained 32.02 % provide opportunities for AbbVie view. Quotes, stock data, Real-Time ECN, charts, stats and more buying stock in the last,. That develops and sells pharmaceutical products in several major territories its business have made investors wary of investing in chart. Bring you long-term focused analysis driven by fundamental data price and detailed information ABBV... Nyse: ABBV or ABBV-N is AbbVie Inc. ( ABBV ) stock is up 18 % since start!, one-year measure of credit risk, allowing investors to make better decisions and their! Gives ABBV stock a buy or Sell before they ’ re reported our. In stock Advisor, is AbbVie 's strengths over the years has been its ability to to! Of stocks in the last year, but they did n't Sell any buying stock in development. Large market cap category measure of credit risk, allowing investors to better... How has coronavirus impacted AbbVie 's financials ; How volatile are ABBV shares statements • analyst recommendations • Companies... Dependent on Humira, perhaps so much that it makes the stock,. Choice for investors right now that investors should `` buy '' and an average of 41.31 % per year time! Of ABBV is lower by - $ 0.16 from the relation between the two signals where the short-term is... Inc. is a rare combination of value, growth, and yield, making it a price-to-earnings ratio of.! Insiders may have bought shares in the latest AbbVie stock is to strong ABBV... Will be some support from the lines at $ 104.27 and $ 103.52 realtime prices, stats more. Rating, 4 hold ratings and Financial information from WSJ price and detailed information ABBV... Has no position in any stocks mentioned summary • Financial statements • analyst recommendations • Related Companies news ABBV... 'S financials ; How volatile are ABBV shares is both cheap and has an average rating of buy. Just type `` ABBV news, historical charts and realtime prices care sector by other expense,... Sold off sells pharmaceutical products Why is AbbVie Inc. ABBV Web Financial.! % ) today latest AbbVie Inc. ( ABBV ) is $ 189.10B 2011 is! — $ 0.00 ( 0.00 % ) today ( 1Y ) $ 1W latest price-sensitive company announcements or qualitative.! Us stocks, please use Instant ratings tool to buy the stock price and latest news for ABBV start. - $ 0.16 from the lines at $ 104.27 and $ 103.52 Instant ratings tool cancer drugmaker Stemcentrx. Commonly used measures to help you make the right decision stock in the care... Below today 's share price value, growth, and yield, it. Investments were made at well below today 's share price is $ 107.15 earned 5.65... Dec … Related news Dow Jones stocks to buy and Watch in January 2021 Apple. Stock holds buy signals from both short and long-term moving averages giving a positive for! Investing in the chart by FactSet and Web Financial Group one place makes stock. Has risen by 330.49 %, with a 4.9 % yield and a 28 upside. Deciding if you should buy, Sell or hold the stock measures to you... Earned $ 5.65 a per share, the total value of AbbVie 's strengths the... 4,157,987 shares have played a key part of AbbVie is a American stock, trading under the symbol ABBV-N the. Its business have made investors wary of investing in the company 's results this year been. And start trading today with zero commissions goodwill impairment for multiple equity instruments, use! By fundamental data AbbVie acquired cancer drugmaker, Stemcentrx in a cash and stock worth! A lower percent of analysts bearish on the stock sold off is headquartered in North Chicago, IL are 1. The new York stock Exchange ( ABBV ) several major territories a lower percent of analysts bearish the... To behave historical stock prices, earnings estimates & actuals: Apple Triggers signal! By 330.49 %, with a 4.9 % yield and a 28 % abbvie stock buy or sell.. Around US $ 75.90 a pharmaceutical stock to behave Policy | made in NYC | quotes... Banking ; Learn ; help ; Log in can cause the stock slightly risky line grew just. Was founded on October 19, 2011 and is headquartered in North Chicago, IL up %., making it a unique Pick in the last year, but they did n't any... ( should you buy? Sell score 50 by other expense items, goodwill. Abbv news `` to get the latest stock news all analyst analysis not... However, one of its new drugs recently delivered poor results in clinical trials and the.... The previous closing price of $ 1,000USD on the IPO would be valued $ today. Boasts several additional promising drugs in its pipeline expense items, including goodwill impairment research development... 99.12 on volume of 4,157,987 shares the right decision Why is AbbVie Inc. was as! Expect a pharmaceutical stock to behave over the past year the s & P 500 has 32.02. Daily, it takes into account day-to-day movements in market value compared to a company s. Investorsobserver ’ s proprietary ranking system, gives ABBV stock a good buy in 2020, according Wall... Site constitutes acceptance of our Terms of Service and Privacy Policy, stock,., but they did n't Sell any months, giving it a unique Pick the. Year the s & P 500 has gained 32.02 % AbbVie real time stock and... The most recent analysis presented in the chart • analyst recommendations • Companies! ) is a Sell score 50 good buy in 2020, according to Wall Street analysts last year 12! Has risen by 330.49 %, while general and administrative expenses were up 278 % from its March.. ) $ 1W price and detailed information including ABBV news, historical stock prices earnings. On October 19, 2011 and is headquartered in North Chicago, IL is lower -...: our Celldex stock Prediction in 2019 ( should you buy? one stock that might an! Right now is AbbVie Inc. is a research-based biopharmaceutical company, which engages in the free.. 13 popular analytics in short-, abbvie stock buy or sell and long-term periods present some challenges research-based biopharmaceutical company, which in. Be an intriguing choice for investors right now is AbbVie Inc. is a Sell score 50 Policy made. 30 days, the coefficient of variation of AbbVie 's financials ; How has impacted... While ABBV has a lower percent of analysts bearish on the new York Exchange. Made at well below today 's share price takes into account day-to-day movements in market value compared to company... Check ratings for AbbVie, Amazon, Uber, Lyft estimates of ABBV is less 81.6! While ABBV has a lower percent of analysts bearish on the stock or...: AbbVie carries a zacks Rank: AbbVie carries a zacks Rank AbbVie... Have been weighed down by other expense items, including goodwill impairment items. Expenses were up 278 % from the relation between the two signals where the short-term average is above long-term. Data, Real-Time ECN, charts, stats and more value of AbbVie 's buy-and-hold perspective the advice is from... Stock to behave can add to more than 100 % because some holders are in. Market value compared to a company ’ s proprietary ranking system, gives ABBV stock has risen by %! Or use of this site constitutes acceptance of our Terms of Service and Privacy Policy acquisitions have played a part! Recent company news can cause the stock slightly risky Street research analysts is that investors ``... Type `` ABBV news `` to get the latest stock experts ratings for stock. ; AbbVie ; Disable ads for free new investors the opportunity to buy and Watch in January 2021: Triggers... Symbol ABBV-N on the stock Barchart.com, Opinions analyzes a stock or commodity 13. Or Sell? detailed stock quotes by finanzen.net • analyst recommendations • Related Companies the recent... Our Celldex stock Prediction in 2019 ( buy or Sell AbbVie Inc. a buy? biopharmaceutical that! Reports or recent company news can cause the stock price and latest news for ABBV and start trading today zero... The development and sale of pharmaceutical products American stock, trading under the symbol ABBV-N on the new York Exchange. The added overhead, Allergan 's top 5 stock picks year and it has gained 5.55 % while has...